Entrada Therapeutics, Inc. (TRDA): Shares Outstanding

Annual figures by period end, from SEC filings.

38.28M
As of 2025-12-31
38.94M
As of 2026-06-30
+6.8%
3-year compound annual growth
+98.4%
5-year compound annual growth
2020-12-31: 1.24M2021-12-31: 31.22M2022-12-31: 31.39M2023-12-31: 33.44M2024-12-31: 37.57M2025-12-31: 38.28M38.28M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3138.28M+1.9%2026-02-26, Balance as of period end
2024-12-3137.57M+12.4%2026-02-26, Balance as of period end
2023-12-3133.44M+6.5%2025-02-27, Balance as of period end
2022-12-3131.39M+0.5%2024-03-13, Balance as of period end
2021-12-3131.22Mn/m2023-03-06, Balance as of period end
2020-12-311.24Mn/a2022-03-15, Balance as of period end